Novo Nordisk A/S Stock price

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen 11:59:47 2024-03-27 am EDT 5-day change 1st Jan Change
881.3 DKK -0.79% Intraday chart for Novo Nordisk A/S -2.29% +26.24%
Sales 2024 * 287B 41.49B Sales 2025 * 345B 49.87B Capitalization 3,932B 569B
Net income 2024 * 103B 14.94B Net income 2025 * 124B 17.92B EV / Sales 2024 * 13.8 x
Net Debt 2024 * 26.04B 3.77B Net Debt 2025 * 3.19B 462M EV / Sales 2025 * 11.4 x
P/E ratio 2024 *
38.1 x
P/E ratio 2025 *
31.3 x
Employees 63,845
Yield 2024 *
1.33%
Yield 2025 *
1.61%
Free-Float 70.47%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Novo Nordisk A/S

1 day-0.79%
1 week-2.29%
Current month+7.51%
1 month+5.68%
3 months+27.36%
6 months+36.11%
Current year+26.24%
More quotes
1 week
877.60
Extreme 877.6
896.70
1 month
817.10
Extreme 817.1
932.00
Current year
688.80
Extreme 688.8
932.00
1 year
504.40
Extreme 504.4
932.00
3 years
211.00
Extreme 211
932.00
5 years
155.08
Extreme 155.075
932.00
10 years
109.10
Extreme 109.1
932.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 90-12-31
Director of Finance/CFO 53 98-12-31
Chief Tech/Sci/R&D Officer - 15-09-30
Members of the board TitleAgeSince
Director/Board Member 63 15-03-18
Chairman 61 17-03-22
Director/Board Member 68 18-02-28
More insiders
Date Price Change Volume
24-03-27 881.3 -0.79% 2,544,307
24-03-26 888.3 -0.69% 2,930,730
24-03-25 894.5 +0.82% 1,462,573
24-03-22 887.2 -0.75% 2,198,005
24-03-21 893.9 -0.90% 3,529,581

Delayed Quote Nasdaq Copenhagen, March 27, 2024 at 11:59 am EDT

More quotes
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
881.3 DKK
Average target price
909.4 DKK
Spread / Average Target
+3.19%
Consensus
  1. Stock
  2. Equities
  3. Stock Novo Nordisk A/S - Nasdaq Copenhagen